Copyright
©The Author(s) 2022.
World J Gastroenterol. May 7, 2022; 28(17): 1814-1829
Published online May 7, 2022. doi: 10.3748/wjg.v28.i17.1814
Published online May 7, 2022. doi: 10.3748/wjg.v28.i17.1814
Gene | 5’-3’ Left | 3’-5’ Right |
Lbp | GGTGGCTGCTGAATCTCTTC | TCTGCTGTGACTGGCAGAGT |
Tlr4 | GCCGGAAGGTTATTGTGGTA | GAAACTGCCATGTTTGAGCA |
Nlrp3 | ATGCTGCTTCGACATCTCCT | GTTTCTGGAGGTTGCAGAGC |
Cd206 | CAAGGAAGGTTGGCATTTGT | CCTTTCAGTCCTTTGCAAGC |
IL-10 | GCCTTATCGGAAATGATCCA | TCCTGAGGGTCTTCAGCTTC |
IL-13 | CTGGATTCCCTGACCAACAT | GGTTACAGAGGCCATGCAAT |
Beta-actin | TGTTACCAACTGGGACGACA | GGGGTGTTGAAGGTCTCAAA |
- Citation: Silva-Veiga FM, Miranda CS, Vasques-Monteiro IML, Souza-Tavares H, Martins FF, Daleprane JB, Souza-Mello V. Peroxisome proliferator-activated receptor-alpha activation and dipeptidyl peptidase-4 inhibition target dysbiosis to treat fatty liver in obese mice . World J Gastroenterol 2022; 28(17): 1814-1829
- URL: https://www.wjgnet.com/1007-9327/full/v28/i17/1814.htm
- DOI: https://dx.doi.org/10.3748/wjg.v28.i17.1814